TheraCea creates radiotracer and detection technology for the development of and application in cancer and neurological therapies.
The Science
The core of our technology is a series of patented chemical processes for the radiolabeling of biomolecules with the isotope Fluorine-18 (18F). Additionally, the company is developing imaging technology capable of simultaneous detection of multiple radiotracers for higher accuracy and better precision.
The Products
TheraCea develops radiotracer kits for in vivo biomarker identification using Positron Emission Tomography (PET) imaging using 18F-radiotracers. These off-the-shelf kits are designed for radiopharmacies and require no specialized training or equipment to prepare 18F material for imaging center use.
The Applications
Tools for acceleration of preclinical studies and clinical trials
TheraCea's diagnostic tools increase the probability of matching high-potential therapies meant to target specific aspects of cancers or neurological disorders to the patients who will potentially benefit the most. Furthermore, the tools allow fast efficacy assessments for pipeline immunotherapy drugs.
Rapid & accurate systemic PET imaging
TheraCea technology can decipher tumor heterogeneity and provide full body imaging. This is a step function improvement over the current standard of care that relies on limited and painful site biopsies for patient classification.
If necessary, additional imaging can take place within days, not weeks to months as is the case with current imaging methods - offering better patient management.
Efficacy Feedback
TheraCea's technology provides accurate therapy matching and rapid treatment efficacy assessments to patients and their oncologists or neurologists in days rather than months (the current standard of care), improving a patient's prognosis by offering the time to employ additional therapies if needed.
TheraCea can assist with custom synthesis of biologicals, radiolabeling, as well as positron emission tomography (PET) imaging. See how TheraCea can assist you with your preclinical trials.